These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 19712857

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibiotic.
    File TM, Monte SV, Schentag JJ, Paladino JA, Klugman KP, Lavin B, Yu VL, Singer ME, Adelman MH.
    Int J Antimicrob Agents; 2009 Jan; 33(1):58-64. PubMed ID: 18835762
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
    Nseir S, Di Pompeo C, Cavestri B, Jozefowicz E, Nyunga M, Soubrier S, Roussel-Delvallez M, Saulnier F, Mathieu D, Durocher A.
    Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
    [Abstract] [Full Text] [Related]

  • 11. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X, Sikirica V, Schein JR, Grant R, Zarotsky V, Doshi D, Benson CJ, Riedel AA.
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The influence of COPD on mortality and severity scoring in community-acquired pneumonia.
    Snijders D, van der Eerden M, de Graaff C, Boersma W.
    Respiration; 2010 Feb; 79(1):46-53. PubMed ID: 19372638
    [Abstract] [Full Text] [Related]

  • 14. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
    Valipour A, Schreder M, Wolzt M, Saliba S, Kapiotis S, Eickhoff P, Burghuber OC.
    Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
    [Abstract] [Full Text] [Related]

  • 15. Influence of steroids on procalcitonin and C-reactive protein in patients with COPD and community-acquired pneumonia.
    Perren A, Cerutti B, Lepori M, Senn V, Capelli B, Duchini F, Domenighetti G.
    Infection; 2008 Mar; 36(2):163-6. PubMed ID: 18330505
    [Abstract] [Full Text] [Related]

  • 16. [C-reactive protein, leukocyte count and ESR in the assessment of severity of community-acquired pneumonia].
    Bircan A, Kaya O, Gökirmak M, Oztürk O, Sahin U, Akkaya A.
    Tuberk Toraks; 2006 Mar; 54(1):22-9. PubMed ID: 16615014
    [Abstract] [Full Text] [Related]

  • 17. [The investigation of the relationship between Leptin-insulin resistance and pulmonary function in patients with chronic obstructive pulmonary disease with acute exacerbation].
    Pan HY, Lu XZ, Wang DX, Zeng Y, Zhong HB.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep; 19(9):519-21. PubMed ID: 17767817
    [Abstract] [Full Text] [Related]

  • 18. Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia.
    Bruns AH, Oosterheert JJ, Hak E, Hoepelman AI.
    Eur Respir J; 2008 Sep; 32(3):726-32. PubMed ID: 18508833
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diagnostic and Prognostic Value of Inflammatory Parameters Including Neopterin in the Setting of Pneumonia, COPD, and Acute Exacerbations.
    Pizzini A, Lunger F, Sahanic A, Nemati N, Fuchs D, Weiss G, Kurz K, Bellmann-Weiler R.
    COPD; 2017 Jun; 14(3):298-303. PubMed ID: 28548632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.